于ARAS患者中筛选经皮肾动脉腔内成形术适应证  

Screening indications of percutaneous transluminal renal angioplasty among patients with atherosclerotic renal artery stenosis

作　　者：杨心志 李鹏宇 张碧辉[1] 闫子光[1] 牛国晨[1] 杨敏[1] YANG Xinzhi;LI Pengyu;ZHANG Bihui;YAN Ziguang;NIU Guochen;YANG Min(Department of Interventional Radiology and Vascular Surgery,Peking University First Hospital,Beijing 100034,China)

机构地区：[1]北京大学第一医院介入血管外科,北京100034

出　　处：《中国介入影像与治疗学》2023年第1期58-61,共4页Chinese Journal of Interventional Imaging and Therapy

摘　　要：动脉粥样硬化性肾动脉狭窄(ARAS)是诱发继发性高血压及缺血性肾病的重要因素,应否采用经皮肾动脉腔内成形术(PTRA)加以治疗目前尚存争议;如何于ARAS患者中筛选PTRA适应证为目前亟待解决的临床问题。本文针对最可能受益于PTRA的ARAS患者的特征进行综述。Atherosclerotic renal artery stenosis(ARAS) is an important factor of secondary hypertension and ischemic nephropathy. Whether ARAS should be treated with percutaneous transluminal renal angioplasty(PTRA) remains controversial. How to select indications of PTRA from ARAS patients is an urgent clinical problem to be solved. The characteristics of ARAS patients who were most likely to benefit from PTRA were reviewed in this article.

关 键 词：动脉粥样硬化 肾动脉梗阻 血管成形术 

分 类 号：R692.9[医药卫生—泌尿科学] R815[医药卫生—外科学]